AHGNasdaqServices-Business Services, NECFiscal year ends March 31

Akso Health Group

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 23, 2026

$1.33−0.02 (-1.48%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): 133.0
Dividend yield: –

Akso Health Group cash flow statement

AnnualQuarterlyTTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2017 2017-03-31	FY 2016 2016-03-31
Depreciation & Amortization	2.37	2.15	–	–	0.02	0.02	0.12	0.02	0.17	0.09	0.06
Stock-Based Compensation	–	–	–	–	0.39	0.06	0.35	6.59	1.83	0	0
Deferred Income Taxes	-1.99	-31	–	–	–	–	0.04	-0.05	0.42	0.14	-0.37
Change in Accounts Receivable	-0.44	-0.86	0.33	-8.10	–	–	–	–	–	–	–
Change in Inventory	–	–	1.50	6.11	-7.80	–	–	–	–	–	–
Change in Accounts Payable	0.31	0.42	0.17	0.71	0.15	-0.04	-0.34	-0.47	2.46	-2.56	1.18
Change in Unearned Revenue	-5.81	9.86	0.22	0.19	–	–	-0.07	0.30	–	–	–
Operating Cash Flow	-13	1.18	1.35	-3.25	-8.63	10	-58	-1.73	88	8.19	7.03
Capital Expenditures	0.00	-0.15	–	–	0.00	–	-0.20	-0.01	-0.46	-0.29	-0.12
Acquisitions	–	-94	-56	–	–	–	–	–	–	–	–
Sale of Property, Plant & Equipment	–	–	–	–	–	–	0.01	0.01	–	–	–
Purchase of Investments	–	–	–	–	–	–	-15	-17	–	–	–
Investing Cash Flow	-163	-106	-55	18	-20	0.00	13	-68	-28	-0.29	-0.12
Dividends Paid	–	–	–	–	–	–	–	-20	–	–	–
Share Repurchases	–	–	–	–	–	–	-2.67	-1.32	–	–	–
Financing Cash Flow	0.35	196	132	-28	35	-9.04	-1.55	-0.03	48	4.29	0.24
Foreign Exchange Rate Adjustments	-0.15	-1.12	-1.27	-0.44	0.61	3.18	0.61	-5.38	5.77	-0.78	-0.28
Net Change in Cash	-176	90	77	-13	6.80	4.20	-46	-75	113	11	6.86
Free Cash Flow	-13	1.02	–	–	-8.63	–	-58	-1.74	87	7.90	6.90
Income Taxes Paid	0.00	0.00	0.02	0.02	0.09	2.11	3.21	12	1.02	0.30	–
Interest Paid	–	–	0.11	0.34	0.68	2.11	2.41	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY2026

Gross margin: -0.1%
Operating margin: -149.7%
Net margin: -135.0%
Return on equity, FY2026: -9.8%

Financial strength

Current ratio: 21.77
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 2.0%

Valuation

P/E ratio: 133.0
Price to sales: –
Price to book: –
Dividend yield: –